Budapest, Hungary

Laszlo Rozsa


Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1980-1990

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Laszlo Rozsa

Introduction

Laszlo Rozsa is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on dioxazocine derivatives. With a total of five patents to his name, Rozsa's inventions have the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents are compositions and methods involving dioxazocine derivatives. These derivatives are represented by specific chemical formulas, where R1 can be hydrogen or an alkyl group with one to four carbon atoms. One of his notable inventions relates to optically active 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12H-dibenzo[d,g][1,3,6]dioxazocine. This compound, along with its pharmaceutically acceptable acid addition salts, has shown particular efficacy against Parkinson's disease. The preparation of these optically active enantiomers is a significant advancement in the field.

Career Highlights

Throughout his career, Laszlo Rozsa has worked with prominent companies in the pharmaceutical industry. Notable among these are Egyt Gyogyszervegyeszeti Gyar and Egis Gyogyszergyar. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical science.

Collaborations

Rozsa has collaborated with several talented individuals in his field. Among his coworkers are Lujza E Petocz and Katalin Grasser, who have contributed to his research and development efforts.

Conclusion

Laszlo Rozsa's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments, particularly for conditions like Parkinson's disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…